Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval

Abiomed (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the launch of a new indication and Women’s Initiative focused on heart recovery education and awareness.

As quoted in the press release:

According to the Centers for Disease Control and Prevention (CDC), cardiovascular disease is the number one killer of women and causes 35% of deaths (approximately 430,000) in American women over the age of 20¹. Two causes of death as a result of cardiogenic shock, specific to the female population are PPCM and spontaneous coronary artery dissection (SCAD).

Click here to read the full press release.